The COPD Pipeline, XXVI.
作者信息
Gross Nicholas
机构信息
Stritch-Loyola School of Medicine, Chicago, Illinois and St. Francis Hospital, Hartford, Connecticut.
出版信息
Chronic Obstr Pulm Dis. 2015 Jan 16;2(1):81-84. doi: 10.15326/jcopdf.2.1.2014.0166.
Abstract
摘要
相似文献
1
The COPD Pipeline, XXVI.慢性阻塞性肺疾病研发管线，第二十六期
Chronic Obstr Pulm Dis. 2015 Jan 16;2(1):81-84. doi: 10.15326/jcopdf.2.1.2014.0166.
2
The development of AZD7624 for prevention of exacerbations in COPD: a randomized controlled trial.AZD7624用于预防慢性阻塞性肺疾病急性加重的研究：一项随机对照试验。
Int J Chron Obstruct Pulmon Dis. 2018 Mar 27;13:1009-1019. doi: 10.2147/COPD.S150576. eCollection 2018.
3
p38 Mitogen-activated protein kinase accelerates emphysema in mouse model of chronic obstructive pulmonary disease.p38丝裂原活化蛋白激酶在慢性阻塞性肺疾病小鼠模型中加速肺气肿进程。
J Recept Signal Transduct Res. 2014 Aug;34(4):299-306. doi: 10.3109/10799893.2014.896380. Epub 2014 Mar 5.
4
Increased phosphorylated p38 mitogen-activated protein kinase in COPD lungs.COPD 肺组织中磷酸化 p38 丝裂原活化蛋白激酶增加。
Eur Respir J. 2013 Jul;42(1):28-41. doi: 10.1183/09031936.00170711. Epub 2012 Oct 11.
5
Protective Effect of Hydroxysafflor Yellow A on Inflammatory Injury in Chronic Obstructive Pulmonary Disease Rats.羟基红花黄色素 A 对慢性阻塞性肺疾病大鼠炎症损伤的保护作用。
Chin J Integr Med. 2019 Oct;25(10):750-756. doi: 10.1007/s11655-018-2577-2. Epub 2018 Dec 27.
6
CD147 increases mucus secretion induced by cigarette smoke in COPD.CD147 增加 COPD 患者香烟烟雾诱导的黏液分泌。
BMC Pulm Med. 2019 Feb 6;19(1):29. doi: 10.1186/s12890-019-0791-0.
7
The effect of phosphatidylinositol-3 kinase inhibition on matrix metalloproteinase-9 and reactive oxygen species release from chronic obstructive pulmonary disease neutrophils.磷脂酰肌醇-3激酶抑制对慢性阻塞性肺疾病中性粒细胞基质金属蛋白酶-9及活性氧释放的影响
Int Immunopharmacol. 2016 Jun;35:155-162. doi: 10.1016/j.intimp.2016.03.027. Epub 2016 Apr 16.
8
In vitro modeling of COPD inflammation and limitation of p38 inhibitor - SB203580.慢性阻塞性肺疾病（COPD）炎症的体外建模及p38抑制剂 - SB203580的局限性
Int J Chron Obstruct Pulmon Dis. 2016 Apr 29;11:909-17. doi: 10.2147/COPD.S99810. eCollection 2016.
9
Annexin A1 is elevated in patients with COPD and affects lung fibroblast function.膜联蛋白A1在慢性阻塞性肺疾病（COPD）患者中升高，并影响肺成纤维细胞功能。
Int J Chron Obstruct Pulmon Dis. 2018 Feb 5;13:473-486. doi: 10.2147/COPD.S149766. eCollection 2018.
10
Up-regulation of Pim-3 in Chronic Obstructive Pulmonary Disease (COPD) patients and its potential therapeutic role in COPD rat modeling.慢性阻塞性肺疾病（COPD）患者中Pim-3的上调及其在COPD大鼠模型中的潜在治疗作用。
Pathol Res Pract. 2017 Apr;213(4):322-326. doi: 10.1016/j.prp.2017.01.018. Epub 2017 Jan 29.
本文引用的文献
1
Cytisine versus nicotine for smoking cessation.烟碱与野靛碱用于戒烟的效果比较。
N Engl J Med. 2014 Dec 18;371(25):2353-62. doi: 10.1056/NEJMoa1407764.
2
The shape of things to come: 3D printing in medicine.未来的形态：医学中的3D打印
JAMA. 2014 Dec 3;312(21):2213-4. doi: 10.1001/jama.2014.9542.
3
What is the clinical effectiveness and cost-effectiveness of cytisine compared with varenicline for smoking cessation? A systematic review and economic evaluation.与伐尼克兰相比，金雀花碱用于戒烟的临床疗效和成本效益如何？一项系统评价和经济学评估。
Health Technol Assess. 2014 May;18(33):1-120. doi: 10.3310/hta18330.
4
The COPD pipeline.
Nat Rev Drug Discov. 2014 Apr;13(4):253. doi: 10.1038/nrd4254. Epub 2014 Mar 14.
5
Efficacy and safety of the p38 MAPK inhibitor losmapimod for patients with chronic obstructive pulmonary disease: a randomised, double-blind, placebo-controlled trial.p38MAPK 抑制剂洛索洛芬对慢性阻塞性肺疾病患者的疗效和安全性：一项随机、双盲、安慰剂对照试验。
Lancet Respir Med. 2014 Jan;2(1):63-72. doi: 10.1016/S2213-2600(13)70200-5. Epub 2013 Dec 5.
6
Bioresorbable airway splint created with a three-dimensional printer.用三维打印机制造的可生物吸收气道夹板。
N Engl J Med. 2013 May 23;368(21):2043-5. doi: 10.1056/NEJMc1206319.
7
P38 inhibition in COPD; cautious optimism.慢性阻塞性肺疾病中P38的抑制作用；谨慎的乐观态度。
Thorax. 2013 Aug;68(8):705-6. doi: 10.1136/thoraxjnl-2013-203498. Epub 2013 Apr 23.
8
Efficacy and safety of the oral p38 inhibitor PH-797804 in chronic obstructive pulmonary disease: a randomised clinical trial.口服 p38 抑制剂 PH-797804 治疗慢性阻塞性肺疾病的疗效和安全性：一项随机临床试验。
Thorax. 2013 Aug;68(8):738-45. doi: 10.1136/thoraxjnl-2012-202744. Epub 2013 Mar 28.
9
Smoking cessation drugs market.戒烟药物市场。
Nat Rev Drug Discov. 2013 Feb;12(2):97-8. doi: 10.1038/nrd3914.
10
An oral inhibitor of p38 MAP kinase reduces plasma fibrinogen in patients with chronic obstructive pulmonary disease.p38MAP 激酶的口服抑制剂可降低慢性阻塞性肺疾病患者的血浆纤维蛋白原。
J Clin Pharmacol. 2012 Mar;52(3):416-24. doi: 10.1177/0091270010397050. Epub 2011 Nov 16.
Zotero 插件